Documentos de Académico
Documentos de Profesional
Documentos de Cultura
crónica
Bauer, K., Rancea, M., Roloff, V., Elter, T., Hallek, M., Engert, A., & Skoetz, N.
(2012). Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for
chronic lymphocytic leukaemia. Cochrane Database of Systematic Reviews,
CD008079(11). https://doi.org/10.1002/14651858.cd008079.pub2
Delgado, J., Nadeu, F., Colomer, D., & Campo, E. (2020). Chronic lymphocytic
leukemia: from molecular pathogenesis to novel therapeutic strategies.
Haematologica, 105(9), 2205–2217. https://doi.org/10.3324/haematol.2019.236000
Klein, C., Lammens, A., Schäfer, W., Georges, G., Schwaiger, M., Mössner, E.,
Hopfner, K. P., Umaña, P., & Niederfellner, G. (2013). Epitope interactions of
monoclonal antibodies targeting CD20 and their relationship to functional properties.
mAbs, 5(1), 22–33. https://doi.org/10.4161/mabs.22771
Salles, G., Barrett, M., Foà, R., Maurer, J., O’Brien, S., Valente, N., Wenger, M., &
Maloney, D. G. (2017). Rituximab in B-Cell Hematologic Malignancies: A Review of
20 Years of Clinical Experience. Advances in Therapy, 34(10), 2232–2273.
https://doi.org/10.1007/s12325-017-0612-x